Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Huvudupphovsman: | Forbes, E |
---|---|
Övriga upphovsmän: | Hill, A |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
2011
|
Ämnen: |
Liknande verk
Liknande verk
-
Pre-clinical development of viral vectored transmission-blocking malaria vaccines
av: Kapulu, MC
Publicerad: (2014) -
Developing novel blood-stage malaria vaccines
av: Douglas, AD
Publicerad: (2015) -
Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
av: Bauza, K
Publicerad: (2012) -
Towards improved blood-stage malaria vaccines: characterising the underlying immunogenicity of vaccine adjuvants and vectors
av: de Cassan, S
Publicerad: (2011) -
Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
av: Elias, SC
Publicerad: (2014)